This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
HMGB3 promotes PARP inhibitor resistance through interacting with PARP1 in ovarian cancer
Cell Death & Disease Open Access 24 March 2022
-
Identification of GSX2 and AF10 as NUP98 partner genes in myeloid malignancies
Blood Cancer Journal Open Access 12 July 2013
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Romana SP, Radford-Weiss I, Ben Abdelali R, Schluth C, Petit A, Dastugue N et al. NUP98 rearrangements in hematopoietic malignancies: a study of the Groupe Francophone de Cytogenetique Hematologique. Leukemia 2006; 20: 696–706.
Moore MA, Chung KY, Plasilova M, Schuringa JJ, Shieh JH, Zhou P et al. NUP98 dysregulation in myeloid leukemogenesis. Ann NY Acad Sci 2007; 1106: 114–142.
Kasper LH, Brindle PK, Schnabel CA, Pritchard CE, Cleary ML, van Deursen JM . CREB binding protein interacts with nucleoporin-specific FG repeats that activate transcription and mediate NUP98-HOXA9 oncogenicity. Mol Cell Biol 1999; 19: 764–776.
Wang GG, Cai L, Pasillas MP, Kamps MP . NUP98-NSD1 links H3K36 methylation to Hox-A gene activation and leukaemogenesis. Nat Cell Biol 2007; 9: 804–812.
Wang GG, Song J, Wang Z, Dormann HL, Casadio F, Li H et al. Haematopoietic malignancies caused by dysregulation of a chromatin-binding PHD finger. Nature 2009; 459: 847–851.
Travers AA . Priming the nucleosome: a role for HMGB proteins? EMBO Rep 2003; 4: 131–136.
Nemeth MJ, Curtis DJ, Kirby MR, Garrett-Beal LJ, Seidel NE, Cline AP et al. Hmgb3: an HMG-box family member expressed in primitive hematopoietic cells that inhibits myeloid and B-cell differentiation. Blood 2003; 102: 1298–1306.
Nemeth MJ, Kirby MR, Bodine DM . Hmgb3 regulates the balance between hematopoietic stem cell self-renewal and differentiation. Proc Natl Acad Sci USA 2006; 103: 13783–13788.
Somervaille TC, Matheny CJ, Spencer GJ, Iwasaki M, Rinn JL, Witten DM et al. Hierarchical maintenance of MLL myeloid leukemia stem cells employs a transcriptional program shared with embryonic rather than adult stem cells. Cell Stem Cell 2009; 4: 129–140.
Su X, Drabkin H, Clappier E, Morgado E, Busson M, Romana SP et al. Transforming potential of the T-cell acute lymphoblastic leukemia-associated homeobox genes HOXA13, TLX1, and TLX3. Genes Chromosomes Cancer 2006; 45: 846–855.
Kroon E, Thorsteinsdottir U, Mayotte N, Nakamura T, Sauvageau G . NUP98-HOXA9 expression in hemopoietic stem cells induces chronic and acute myeloid leukemias in mice. EMBO J 2001; 20: 350–361.
Kogan SC, Ward JM, Anver MR, Berman JJ, Brayton C, Cardiff RD et al. Bethesda proposals for classification of nonlymphoid hematopoietic neoplasms in mice. Blood 2002; 100: 238–245.
Akashi K, Traver D, Miyamoto T, Weissman IL . A clonogenic common myeloid progenitor that gives rise to all myeloid lineages. Nature 2000; 404: 193–197.
Cozzio A, Passegue E, Ayton PM, Karsunky H, Cleary ML, Weissman IL . Similar MLL-associated leukemias arising from self-renewing stem cells and short-lived myeloid progenitors. Genes Dev 2003; 17: 3029–3035.
Krivtsov AV, Armstrong SA . MLL translocations, histone modifications and leukaemia stem-cell development. Nat Rev Cancer 2007; 7: 823–833.
Palmqvist L, Pineault N, Wasslavik C, Humphries RK . Candidate genes for expansion and transformation of hematopoietic stem cells by NUP98-HOX fusion genes. PLoS ONE 2007; 2: e768.
Hirose K, Abramovich C, Argiropoulos B, Humphries RK . Leukemogenic properties of NUP98-PMX1 are linked to NUP98 and homeodomain sequence functions but not to binding properties of PMX1 to serum response factor. Oncogene 2008; 27: 6056–6067.
Jankovic D, Gorello P, Liu T, Ehret S, La Starza R, Desjobert C et al. Leukemogenic mechanisms and targets of a NUP98/HHEX fusion in acute myeloid leukemia. Blood 2008; 111: 5672–5682.
Acknowledgements
We thank Julie Bergeron for help in analyses of PB and BM smears. AP acknowledges the support from the Fondation pour la Recherche Medicale (FRM; Paris, France) and Association pour la recherche sur le Cancer (ARC; Villejuif, France). This work was funded by grants from ARC and Institut National du Cancer (INCa).
Author information
Authors and Affiliations
Corresponding authors
Rights and permissions
About this article
Cite this article
Petit, A., Ragu, C., Della-Valle, V. et al. NUP98–HMGB3: a novel oncogenic fusion. Leukemia 24, 654–658 (2010). https://doi.org/10.1038/leu.2009.241
Published:
Issue Date:
DOI: https://doi.org/10.1038/leu.2009.241
This article is cited by
-
HMGB3 promotes PARP inhibitor resistance through interacting with PARP1 in ovarian cancer
Cell Death & Disease (2022)
-
The role of high mobility group protein B3 (HMGB3) in tumor proliferation and drug resistance
Molecular and Cellular Biochemistry (2021)
-
Overexpression of HMGB3 protein promotes cell proliferation, migration and is associated with poor prognosis in urinary bladder cancer patients
Tumor Biology (2015)
-
Functional and molecular features of the calmodulin-interacting protein IQCG required for haematopoiesis in zebrafish
Nature Communications (2014)
-
Upregulation of miR-513b inhibits cell proliferation, migration, and promotes apoptosis by targeting high mobility group-box 3 protein in gastric cancer
Tumor Biology (2014)